Trial intelligence / Profile preview

BRAIS: Butylphthalide Combined with rtPA for Acute Ischemic Stroke

NCT03394950Phase 4Completed

Start
May 2018
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of butylphthalide in ischemic stroke. Started May 2018; status: completed.

02

Drugs

butylphthalide
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT03394950.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03394950.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call